Collectively, our findings establish PRMT7 as a key regulator of SOX9 stability and function, thereby highlighting the PRMT7-SOX9 axis as a promising therapeutic target in NSCLC. The gene discussed is SOX9; the disease is non-small cell lung carcinoma.